Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial.

Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, Hansson L, Magnani B, Rahn KH, Reid JL, Rodicio J, Safar M, Eckes L, Rizzini P; European Lacidipine Study on Atherosclerosis investigators.

Circulation. 2002 Nov 5;106(19):2422-7.

2.

Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA).

Zanchetti A, Bond MG, Hennig M, Tang R, Hollweck R, Mancia G, Eckes L, Micheli D; ELSA Investigators.

J Hypertens. 2004 Jun;22(6):1201-12.

PMID:
15167456
3.

Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis.

Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, Hansson L, Magnani B, Rahn KH, Reid J, Rodicio J, Safar M, Eckes L, Ravinetto R.

J Hypertens. 1998 Jul;16(7):949-61.

PMID:
9794735
4.

Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness.

Zanchetti A, Hennig M, Baurecht H, Tang R, Cuspidi C, Carugo S, Mancia G.

J Hypertens. 2007 Dec;25(12):2463-70.

PMID:
17984668
5.

Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis.

Mancia G, Facchetti R, Parati G, Zanchetti A.

Circulation. 2012 Jul 31;126(5):569-78. doi: 10.1161/CIRCULATIONAHA.112.107565. Epub 2012 Jul 3.

6.

Carotid wall composition in hypertensive patients after 4-year treatment with lacidipine or atenolol: an echoreflectivity study.

Paliotti R, Ciulla MM, Hennig M, Tang R, Bond MG, Mancia G, Magrini F, Zanchetti A.

J Hypertens. 2005 Jun;23(6):1203-9.

PMID:
15894896
7.
8.
9.

Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study.

Stumpe KO, Agabiti-Rosei E, Zielinski T, Schremmer D, Scholze J, Laeis P, Schwandt P, Ludwig M; MORE study investigators.

Ther Adv Cardiovasc Dis. 2007 Dec;1(2):97-106. doi: 10.1177/1753944707085982.

PMID:
19124398
10.

Potential modification of plaque behavior through the European lacidipine study on atherosclerosis.

Bond MG, Mercuri M.

J Cardiovasc Pharmacol. 1995;25 Suppl 3:S11-6.

PMID:
8852539
11.

Lacidipine: a review of its use in the management of hypertension.

McCormack PL, Wagstaff AJ.

Drugs. 2003;63(21):2327-56. Review.

PMID:
14524737
12.

Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA).

Agabiti-Rosei E, Trimarco B, Muiesan ML, Reid J, Salvetti A, Tang R, Hennig M, Baurecht H, Parati G, Mancia G, Zanchetti A; ELSA Echocardiographic Substudy Group.

J Hypertens. 2005 May;23(5):1091-8.

PMID:
15834297
13.
14.

Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA).

Tang R, Hennig M, Thomasson B, Scherz R, Ravinetto R, Catalini R, Rubba P, Zanchetti A, Bond MG.

J Hypertens. 2000 Feb;18(2):197-201.

PMID:
10694188
16.

Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA).

Zanchetti A, Hennig M, Hollweck R, Bond G, Tang R, Cuspidi C, Parati G, Facchetti R, Mancia G.

Circulation. 2009 Sep 22;120(12):1084-90. doi: 10.1161/CIRCULATIONAHA.108.773119. Epub 2009 Sep 8.

17.

Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials.

Wang JG, Staessen JA, Li Y, Van Bortel LM, Nawrot T, Fagard R, Messerli FH, Safar M.

Stroke. 2006 Jul;37(7):1933-40. Epub 2006 Jun 8.

19.

[Effects of antihypertensive treatment on carotid vascular changes].

Pompeo F, De Luca N, Marchegiano R, Gisonni P, Iovino G, D'Auria F, Del Mastro L, Simonelli P, Trimarco B.

Minerva Cardioangiol. 1994 Nov;42(11):511-5. Italian.

PMID:
7700540
20.

Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study.

Baguet JP, Asmar R, Valensi P, Nisse-Durgeat S, Mallion JM.

Vasc Health Risk Manag. 2009;5(1):175-83. Epub 2009 Apr 8.

Supplemental Content

Support Center